Abstract
Background
Gangliogliomas are neoplastic lesions composed by a mixed population of neoplastic glial and dysplastic neural cells. They represent around 5% of all CNS tumors in the pediatric population. These usually are well-differentiated, slow-growing tumors, meaning that complete resection could cure most of these patients. Although most lesions remain stable over time after incomplete resection, some patients develop progression of the residual lesions: the optimal approach to treat these tumors is still to be defined.
Methods
This is a retrospective study in which we obtained data from medical records of pediatric patients who had a histological diagnosis of ganglioglioma following surgical treatment at a single center between 2001 and 2020.
Results
We included 17 pediatric subjects with gangliogliomas. The median age at diagnosis was 6.7 years, and the median follow-up duration was 60 months. The most common clinical presentation was epileptic seizures (41.1%). Hydrocephalus was present in 29.4% of cases. 52.9% of tumors involved exclusively the cerebral hemispheres, with the temporal lobe being the most affected location. Gross total tumor resection (GTR) was accomplished in 47% of all cases and in 75% of hemispheric tumors. Of patients, 33% in whom GTR could not be achieved showed progression of the residual tumor. BRAF V600E mutation was present in 44.4% of cases.
Conclusion
Gangliogliomas are typically grade I tumors that occasionally affect children. They classically localize in the cerebral hemisphere but may involve deep structures like the basal ganglia, brain stem, and cerebellum, which seems to be particularly frequent in the pediatric population, implying further challenge to achieve adequate oncological control with surgery as the only treatment modality. Although most cases in which GTR could not be performed remained stable over the follow-up, significant progression of the tumor remains was observed in some patients. BRAF inhibitors should be considered as a feasible treatment option in this setting.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Dudley RW, Torok MR, Gallegos DR, Mulcahy-Levy JM, Hoffman LM, Handler MH, Hankinson TC (2015) Pediatric low-grade ganglioglioma: epidemiology, treatments, and outcome analysis on 348 children from the surveillance, epidemiology, and end results database. Neurosurgery 76:313–320
Louis DN, Perry A, Reifenberger G, Von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization Classification of Tumors of the Central Nervous System: A Summary. Acta Neuropathol 131:803–820
Dahiya S, Haydon DH, Alvarado D, Gurnett CA, Gutmann DH, Leonard JR (2013) BRAF(V600E) mutation is a negative prognosticator in pediatric ganglioglioma. Acta Neuropathol 125:901–910
Blümcke I, Wiestler OD (2002) Gangliogliomas: an intriguing tumor entity associated with focal epilepsies. J Neuropathol Exp Neurol 61:575–584
Pekmezci M, Villanueva-Meyer JE, Goode B, Van Ziffle J, Onodera C, Grenert JP, Bastian BC, Chamyan G, Maher OM, Khatib Z, Kleinschmidt-DeMasters BK, Samuel D, Mueller S, Banerjee A, Clarke JL, Cooney T, Torkildson J, Gupta N, Theodosopoulus P, Chang EF, Berger M, Bollen AW, Perry A, Tihan T, Solomon DA (2018) The genetic landscape of ganglioglioma. Acta Neuropathol Commun 6:47
Selvanathan SK, Hammouche S, Salminen HJ, Jenkinson MD (2011) Outcome and prognostic features in anaplastic ganglioglioma: analysis of cases from the SEER database. J Neuro-Oncol 105:539–545
Oushy S, Perry A, Graffeo CS, Carlstrom LP, Daniels DJ (2019) Pediatric ganglioglioma of the brainstem and cervicomedullary junction: a retrospective cohort study. J Neurosurg Pediatr:1–7
Patibandla MR, Ridder T, Dorris K, Torok MR, Liu AK, Handler MH, Stence NV, Fenton LZ, Hankinson TC (2016) Atypical pediatric ganglioglioma is common and associated with a less favorable clinical course. J Neurosurg Pediatr 17:41–48
International Consortium on Low Grade Glioma of the International Society for Pediatric Oncology. (2004). SIOP-LGG-2004: cooperative multicenter study for children and adolescents with low grade glioma (Phase III). [Online]. Available: https://www.birmingham.ac.uk/Documents/college-mds/trials/crctu/archive/lgg2/SIOP-LGG-2004-Version-3.0a-14Sep2010-final-Clean.pdf
Indelicato DJ, Rotondo RL, Uezono H, Sandler ES, Aldana PR, Ranalli NJ, Beier AD, Morris CG, Bradley JA (2019) Outcomes following proton therapy for pediatric low-grade glioma. Int J Radiat Oncol Biol Phys 104(1):149–156
Gnekow AK, Kandels D, van Tilburg C, Azizi AA, Opocher E, Stokland T, Driever PH, Schouten-van Meeteren AYN, Thomale UW, Schuhmann MU, Czech T, Goodden JR, Warmuth-Metz M, Bison B, Avula S, Kortmann R-D, Timmermann B, Pietsch T, Witt O (2019) SIOP-E-BTG and GPOH Guidelines for Diagnosis and Treatment of Children and Adolescents with Low Grade Glioma. Klin Padiatr 231(3):107–135
Bitterman DS, MacDonald SM, Yock TI, Tarbell NJ, Wright KD, Chi SN, Marcus KJ, Haas-Kogan DA (2019) Revisiting the role of radiation therapy for pediatric low-grade glioma. J Clin Oncol 37(35):3335–3339
Greenberger BA, Pulsifer MB, Ebb DH, MacDonald SM, Jones RM, Butler WE, Huang MS, Marcus KJ, Oberg JA, Tarbell NJ, Yock TI (2014) Clinical outcomes and late endocrine, neurocognitive, and visual profiles of proton radiation for pediatric low-grade gliomas. Int J Radiat Oncol Biol Phys 89(5):1060–1068
Philippe L, Maria K, Tariq A, Sofia M, Christine SM, Jean-Pierre F, Dudley RW, Sébastien P, Nada J, Valérie L (2019) Efficacy of Dabrafenib for Three Children With Brainstem BRAF V600E positive ganglioglioma. J Neuro-Oncol 145:135–141
Rush S, Foreman N, Liu A (2013) Brainstem ganglioglioma successfully treated with vemurafenib. J Clin Oncol:159–160
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Declarations of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Quiroz Tejada, A.R., Miranda-Lloret, P., Llavador Ros, M. et al. Gangliogliomas in the pediatric population. Childs Nerv Syst 37, 831–837 (2021). https://doi.org/10.1007/s00381-020-04900-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-020-04900-3